[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-171385-105":53,"doc-detail-171385-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","clinical-study-report-template-galderma-iis","Clinical Study Report Template - Galderma IIS","","Clinical Study Report Template designed to structure a complete clinical study deliverable, starting with the Title Page and Synopsis, followed by Investigator signature and navigational elements like a Table of Contents. It covers governance and compliance through ethics sections, including institutional review board, ethical conduct, and subject information and consent. The template then defines study rationale, objectives, investigational plan, patient disposition, efficacy and safety evaluations, statistical methods, and required appendices and reference materials for reporting results.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":46,"@type":70,"position":76},"https://docshare.wps.com/template/paper-templates/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/clinical-study-report-template-galderma-iis/171385/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/clinical-study-report-template-galderma-iis/171385.png","ImageObject",442,249,{"name":88,"@type":89},"Skyler","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-10-07","2026-09-01",true,{"@type":98,"interactionType":99,"userInteractionCount":15},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What core sections are included in the Clinical Study Report Template?","Question",{"text":108,"@type":109},"The template includes a Title Page, Synopsis, Investigator’s Signature, Table of Contents, and major reporting sections covering ethics, study design, patients, efficacy evaluation, safety evaluation, discussion, references, and appendices.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"How does the template address ethics and participant consent?",{"text":113,"@type":109},"It includes an Ethics section with subsections for institutional review board, ethical conduct of the study, and subject information and consent.",{"name":115,"@type":106,"acceptedAnswer":116},"What does the template require for efficacy and safety reporting?",{"text":117,"@type":109},"It provides dedicated sections for efficacy evaluation (including analyzed data sets, baseline characteristics, compliance, and efficacy results) and safety evaluation (including exposure, adverse events, serious adverse events, lab and vital sign assessments, and safety conclusions).","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},171385,1790240177,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":45,"category_name":46,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":15,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":20,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":47},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","CLINICAL STUDY REPORT\nStudy Title\nInvestigator\nTitle Page\nSynopsis\nInvestigator’s Signature\nTable of Contents\n\u0003\n\u0013 TOC \\o \"1-3\" \\h \\z \\u \u0014\u0013 HYPERLINK \\l \"_Toc49772067\" \u00141.\tTitle Page\t\u0013 PAGEREF _Toc49772067 \\h \u00142\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772068\" \u00142.\tSynopsis\t\u0013 PAGEREF _Toc49772068 \\h \u00143\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772069\" \u0014Investigator’s Signature\t\u0013 PAGEREF _Toc49772069 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772070\" \u00143.\tTable of Contents\t\u0013 PAGEREF _Toc49772070 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772071\" \u00144.\tList of Abbreviations and Definition of Terms\t\u0013 PAGEREF _Toc49772071 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772072\" \u00145.\tEthics\t\u0013 PAGEREF _Toc49772072 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772073\" \u00145.1\tInstitutional Review Board\t\u0013 PAGEREF _Toc49772073 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772074\" \u00145.2\tEthical Conduct of the Study\t\u0013 PAGEREF _Toc49772074 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772075\" \u00145.3\tSubject Information and Consent\t\u0013 PAGEREF _Toc49772075 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772076\" \u00146.\tInvestigators and Study Administrative Structure\t\u0013 PAGEREF _Toc49772076 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772077\" \u00147.\tIntroduction\t\u0013 PAGEREF _Toc49772077 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772078\" \u00148.\tStudy Objectives\t\u0013 PAGEREF _Toc49772078 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772079\" \u00149.\tInvestigational Plan\t\u0013 PAGEREF _Toc49772079 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772080\" \u00149.1\tOverall Study Design\t\u0013 PAGEREF _Toc49772080 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772081\" \u00149.2\tDiscussion of Study Design\t\u0013 PAGEREF _Toc49772081 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772082\" \u00149.3\tSelection of Study Population\t\u0013 PAGEREF _Toc49772082 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772083\" \u00149.4\tTreatments\t\u0013 PAGEREF _Toc49772083 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772084\" \u00149.5\tEfficacy and Safety Variables\t\u0013 PAGEREF _Toc49772084 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772085\" \u00149.6\tData Quality Assurance\t\u0013 PAGEREF _Toc49772085 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772086\" \u00149.7\tStatistical Methods Planned in the Protocol and Determination of Sample Size\t\u0013 PAGEREF _Toc49772086 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772087\" \u00149.8\tChanges in the Conduct of the Study or Planned Analyses\t\u0013 PAGEREF _Toc49772087 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772088\" \u001410.\tStudy Patients\t\u0013 PAGEREF _Toc49772088 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772089\" \u001410.1\tDisposition of Patients\t\u0013 PAGEREF _Toc49772089 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772090\" \u001410.2\tProtocol Deviations\t\u0013 PAGEREF _Toc49772090 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772091\" \u001411.\tEfficacy Evaluation\t\u0013 PAGEREF _Toc49772091 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772092\" \u001411.1\tData Sets Analyzed\t\u0013 PAGEREF _Toc49772092 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772093\" \u001411.2\tDemographic and Other Baseline Characteristics\t\u0013 PAGEREF _Toc49772093 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772094\" \u001411.3\tTreatment Compliance\t\u0013 PAGEREF _Toc49772094 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772095\" \u001411.4\tEfficacy Results and Tabulations of Individual Subject Data\t\u0013 PAGEREF _Toc49772095 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772096\" \u001412.\tSafety Evaluation\t\u0013 PAGEREF _Toc49772096 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772097\" \u001412.1\tExtent of Exposure\t\u0013 PAGEREF _Toc49772097 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772098\" \u001412.2\tAdverse Events (AEs)\t\u0013 PAGEREF _Toc49772098 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772099\" \u001412.3\tDeaths, Other Serious Adverse Events, and Other Significant Adverse Events\t\u0013 PAGEREF _Toc49772099 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772100\" \u001412.4\tClinical Laboratory Evaluation\t\u0013 PAGEREF _Toc49772100 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772101\" \u001412.5\tVital Signs, Physical Findings, and Other Observations Related to Safety\t\u0013 PAGEREF _Toc49772101 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772102\" \u001412.6\tSafety Conclusions\t\u0013 PAGEREF _Toc49772102 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772103\" \u001413.\tDiscussion and Overall Conclusions\t\u0013 PAGEREF _Toc49772103 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772104\" \u001414.\tTables, Figures and Graphs (referred to but not included in the text)\t\u0013 PAGEREF _Toc49772104 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772105\" \u001415.\tReference List\t\u0013 PAGEREF _Toc49772105 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc49772106\" \u001416.\tAppendices\t\u0013 PAGEREF _Toc49772106 \\h \u001414","cbCaidg58sg3tLFZ","https://ap.wps.com/l/cbCaidg58sg3tLFZ","docx",47190,"English","# Title Page\n## Synopsis\n## Investigator’s Signature\n# Table of Contents\n## List of Abbreviations and Definition of Terms\n## Ethics\n## Investigators and Study Administrative Structure\n## Introduction\n## Study Objectives\n## Investigational Plan\n## Study Patients\n## Efficacy Evaluation\n## Safety Evaluation\n## Discussion and Overall Conclusions\n## Tables, Figures and Graphs (referred to but not included in the text)\n## Reference List\n## Appendices","[{\"question\":\"What core sections are included in the Clinical Study Report Template?\",\"answer\":\"The template includes a Title Page, Synopsis, Investigator’s Signature, Table of Contents, and major reporting sections covering ethics, study design, patients, efficacy evaluation, safety evaluation, discussion, references, and appendices.\"},{\"question\":\"How does the template address ethics and participant consent?\",\"answer\":\"It includes an Ethics section with subsections for institutional review board, ethical conduct of the study, and subject information and consent.\"},{\"question\":\"What does the template require for efficacy and safety reporting?\",\"answer\":\"It provides dedicated sections for efficacy evaluation (including analyzed data sets, baseline characteristics, compliance, and efficacy results) and safety evaluation (including exposure, adverse events, serious adverse events, lab and vital sign assessments, and safety conclusions).\"}]","Clinical Study Report Template - Galderma IIS | DOCX",1788282405]